159 related articles for article (PubMed ID: 15794671)
21. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
[TBL] [Abstract][Full Text] [Related]
22. [Adult renal neoplasms in the material of the Pathology Department of the Szeged University].
Németh I; Sükösd F; Béli L; Kiss A; Pajor L; Mikó T; Iványi B
Orv Hetil; 2005 Apr; 146(14):653-8. PubMed ID: 15889540
[TBL] [Abstract][Full Text] [Related]
23. Prognostic stratification of localized renal cell carcinoma by tumor size.
Bedke J; Pritsch M; Buse S; Jakobi H; Elsaesser KH; Pahernik S; Haferkamp A; Hohenfellner M
J Urol; 2008 Jul; 180(1):62-7. PubMed ID: 18485376
[TBL] [Abstract][Full Text] [Related]
24. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
[TBL] [Abstract][Full Text] [Related]
25. Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients.
Schachter LR; Cookson MS; Chang SS; Smith JA; Dietrich MS; Jayaram G; Herrell SD
J Endourol; 2007 Aug; 21(8):819-23. PubMed ID: 17867935
[TBL] [Abstract][Full Text] [Related]
26. Histopathological pattern of renal cell carcinoma in Ibadan.
Odubanjo MO; Oluwasola AO; Ikuerowo SO; Akang EE
Afr J Med Med Sci; 2010 Dec; 39(4):317-21. PubMed ID: 21735998
[TBL] [Abstract][Full Text] [Related]
27. Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.
Gettman MT; Blute ML; Spotts B; Bryant SC; Zincke H
Cancer; 2001 Jan; 91(2):354-61. PubMed ID: 11180082
[TBL] [Abstract][Full Text] [Related]
28. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856
[TBL] [Abstract][Full Text] [Related]
29. Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors.
Pitz S; Moll R; Störkel S; Thoenes W
Lab Invest; 1987 Jun; 56(6):642-53. PubMed ID: 2439772
[TBL] [Abstract][Full Text] [Related]
30. Age and gender related differences in renal cell carcinoma in a European cohort.
Hew MN; Zonneveld R; Kümmerlin IP; Opondo D; de la Rosette JJ; Laguna MP
J Urol; 2012 Jul; 188(1):33-8. PubMed ID: 22578731
[TBL] [Abstract][Full Text] [Related]
31. Clear cell, papillary and chromophobe renal cell carcinoma in patients younger than 20 years old: a clinicopathologic study with follow-up.
Wang J; Shehata BM; Langness SM; Davis GK; Cheng L; Osunkoya AO
J Pediatr Urol; 2012 Oct; 8(5):531-4. PubMed ID: 22018933
[TBL] [Abstract][Full Text] [Related]
32. Comparative Analysis of Smoking as a Risk Factor among Renal Cell Carcinoma Histological Subtypes.
Patel NH; Attwood KM; Hanzly M; Creighton TT; Mehedint DC; Schwaab T; Kauffman EC
J Urol; 2015 Sep; 194(3):640-6. PubMed ID: 25896558
[TBL] [Abstract][Full Text] [Related]
33. Risk factors, classification, and staging of renal cell cancer.
Laber DA
Med Oncol; 2006; 23(4):443-54. PubMed ID: 17303902
[TBL] [Abstract][Full Text] [Related]
34. [Non-clear cell renal carcinoma: comparative analysis of the new and old histological classification in 79 cases].
Cui W; Zhang YH; Chen M; Liu SX; Liu YX; Yang XJ; Yao X
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):772-6. PubMed ID: 21163070
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic radical nephrectomy for large renal masses: critical assessment of perioperative and oncologic outcomes of stage T2a and T2b tumors.
Pierorazio PM; Hyams ES; Lin BM; Mullins JK; Allaf ME
Urology; 2012 Mar; 79(3):570-5. PubMed ID: 22386399
[TBL] [Abstract][Full Text] [Related]
36. T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas.
Bonsib SM
J Urol; 2005 Oct; 174(4 Pt 1):1199-202; discussion 1202. PubMed ID: 16145369
[TBL] [Abstract][Full Text] [Related]
37. [WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?].
Moch H
Pathologe; 2016 Mar; 37(2):127-33. PubMed ID: 26942728
[TBL] [Abstract][Full Text] [Related]
38. Multilocular Cystic Renal Cell Carcinoma: Pathological T Staging Makes No Difference to Favorable Outcomes and Should be Reclassified.
Bhatt JR; Jewett MA; Richard PO; Kawaguchi S; Timilshina N; Evans A; Alibhai S; Finelli A
J Urol; 2016 Nov; 196(5):1350-1355. PubMed ID: 27341751
[TBL] [Abstract][Full Text] [Related]
39. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes.
Renshaw AA; Granter SR; Fletcher JA; Kozakewich HP; Corless CL; Perez-Atayde AR
Am J Surg Pathol; 1999 Jul; 23(7):795-802. PubMed ID: 10403302
[TBL] [Abstract][Full Text] [Related]
40. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
